Antidepressant Use and Progression of Mild to Moderate Alzheimer's Disease: Results from the European ICTUS Cohort

Neuropsychiatric symptoms (NPS) are a core and troubling feature among patients with Alzheimer disease (AD). Because of growing safety warnings against antipsychotics, the use of antidepressants (ATD) in AD has increased extensively. We investigated the potential long-term associations between ATD exposure and functional and cognitive progression in patients with mild to moderate AD.

https://www.jamda.com/article/S1525-8610(20)30539-9/fulltext?rss=yes

Source: Journal of the American Medical Directors Association - July 27, 2020 Category: Health Management Authors: Anne-Bahia Abdeljalil, Ad élaïde de Mauléon, Marion Baziard, Bruno Vellas, Maryse Lapeyre-Mestre, Maria Soto Tags: Original Study Source Type: research